- LL.M. from Instituto de Empresa (2001)
- J.D. from Universidad Complutense de Madrid (2000)
Israel de Diego, partner of the Mergers and Acquisitions department of Araoz & Rueda since 2017, joined our firm after three years as a partner in the M&A and Capital Markets department of Baker McKenzie (2014-2017).
Before joining Baker McKenzie, he worked for five years in the M&A and Capital Markets department of Ramón y Cajal Abogados (the last three years as a partner) and in the corporate and commercial department of other law firms.
Israel has more than fifteen years of experience in all kinds of national and cross-border transactions involving the purchase and sale of companies, assets and liabilities and branches of activity, corporate and debt restructurings and planning of corporate structures, issuance of equity and debt securities and general corporate and commercial contracting, advising also boards of directors of both listed and unlisted companies.
The 'always available' Araoz & Rueda 'understands its client's needs and tries its best to reach them'. The group frequently handles cross-border transactions: it advised German pharmaceutical company Dermapharm on the acquisition of Trommsdorff from Ferrer, and assisted French nursing home group Orpea Group with the acquisition of psychiatry centre Clínica López Ibor. Partner Pedro Rueda heads the corporate and M&A team, which saw the addition of Israel de Diego from Baker McKenzie in November 2017.The EMEA Legal 500 2019